Jakesz, R; Kaufmann, M; Gnant, M; Jonat, W; Mittlboeck, M; Greil, R; Tausch, C; Hilfrich, J; Kwasny, W; Samonigg, H.
Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3,123 women enrolled in the ABCSG trial 8 and the ARNO 95 trial
BREAST CANCER RES TREAT. 2004; 88: S7-S7.
Web of Science